Glaxo Grp Ltd patents expiration
1. Advair Diskus 100/50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-84) | Mar 31, 2012 |
| M(M-214) | Dec 20, 2020 |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 24 August, 2000
Treatment: NA
Dosage: POWDER;INHALATION
ADVAIR DISKUS 100/50 family patents
2. Advair Diskus 250/50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-84) | Mar 31, 2012 |
| M(M-214) | Dec 20, 2020 |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 24 August, 2000
Treatment: NA
Dosage: POWDER;INHALATION
ADVAIR DISKUS 250/50 family patents
3. Advair Diskus 500/50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-84) | Mar 31, 2012 |
| M(M-214) | Dec 20, 2020 |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 24 August, 2000
Treatment: NA
Dosage: POWDER;INHALATION
ADVAIR DISKUS 500/50 family patents
4. Advair Hfa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6251368 | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Dec, 2012
(11 years ago) | |
|
US6251368 (Pediatric) | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Jun, 2013
(10 years ago) | |
| US6596260 | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug, 2014
(9 years ago) | |
| US5658549 | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Aug, 2014
(9 years ago) | |
| US5674472 | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Oct, 2014
(9 years ago) | |
|
US6596260 (Pediatric) | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb, 2015
(9 years ago) | |
|
US5658549 (Pediatric) | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Feb, 2015
(9 years ago) | |
|
US5674472 (Pediatric) | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Apr, 2015
(9 years ago) | |
| US6966467 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6510969 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6315173 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6170717 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6435372 | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jan, 2018
(6 years ago) | |
| US6161724 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6938796 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US7143908 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6997349 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6431168 | GLAXO GRP LTD | Dispenser with doses′ counter |
Jun, 2018
(5 years ago) | |
| US7107986 | GLAXO GRP LTD | Dispenser with doses' counter |
Jun, 2018
(5 years ago) | |
|
US6966467 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6315173 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6510969 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6170717 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6997349 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6161724 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US7143908 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6938796 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6435372 (Pediatric) | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jul, 2018
(5 years ago) | |
| US7350676 | GLAXO GRP LTD | Valve for aerosol container |
Aug, 2018
(5 years ago) | |
|
US7107986 (Pediatric) | GLAXO GRP LTD | Dispenser with doses' counter |
Dec, 2018
(5 years ago) | |
|
US6431168 (Pediatric) | GLAXO GRP LTD | Dispenser with doses′ counter |
Dec, 2018
(5 years ago) | |
|
US7350676 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Feb, 2019
(5 years ago) | |
| US9861771 | GLAXO GRP LTD | Device housing for an aerosol container |
Oct, 2020
(3 years ago) | |
| US6743413 | GLAXO GRP LTD | Suspension aerosol formulations |
Jun, 2021
(2 years ago) | |
|
US6743413 (Pediatric) | GLAXO GRP LTD | Suspension aerosol formulations |
Dec, 2021
(2 years ago) | |
| US7832351 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Jun, 2023
(10 months ago) | |
|
US7832351 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Dec, 2023
(4 months ago) | |
| US7500444 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Feb, 2026
(1 year, 10 months from now) | |
|
US7500444 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Aug, 2026
(2 years from now) | |
Drugs and Companies using FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE ingredient
Market Authorisation Date: 08 June, 2006
Treatment: Indicated for the long-term, twice-daily maintenance treatment of asthma in patients 12 years of age or older; Treatment of asthma in patients aged 12 years and older
Dosage: AEROSOL, METERED;INHALATION
ADVAIR HFA family patents
5. Breo Ellipta patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US7101866 | GLAXO GRP LTD | Anti-inflammatory androstane derivative |
Aug, 2021
(2 years ago) | |
| US7361787 | GLAXO GRP LTD | Phenethanolamine derivatives for treatment of respiratory diseases |
Mar, 2023
(1 year, 29 days ago) | |
| USRE44874 | GLAXO GRP LTD | Phenethanolamine derivatives for treatment of respiratory diseases |
Mar, 2023
(1 year, 29 days ago) | |
| US7439393 | GLAXO GRP LTD | Phenethanolamine derivatives for treatment of respiratory diseases |
May, 2025
(1 year, 30 days from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
| US6878698 | GLAXO GRP LTD | Anti-inflammatory androstane derivatives |
Aug, 2021
(2 years ago) | |
| US7629335 | GLAXO GRP LTD | Anti-inflammatory androstane derivative |
Aug, 2021
(2 years ago) | |
| US6759398 | GLAXO GRP LTD | Anti-inflammatory androstane derivative |
Aug, 2021
(2 years ago) | |
| US6537983 | GLAXO GRP LTD | Anti-inflammatory androstane derivatives |
Aug, 2021
(2 years ago) | |
| US7776895 | GLAXO GRP LTD | Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases |
Sep, 2022
(1 year, 7 months ago) | |
|
US7439393 (Pediatric) | GLAXO GRP LTD | Phenethanolamine derivatives for treatment of respiratory diseases |
Nov, 2025
(1 year, 7 months from now) | |
| US8511304 | GLAXO GRP LTD | Medicament dispenser |
Jun, 2027
(3 years from now) | |
| US9333310 | GLAXO GRP LTD | Medicament dispenser |
Oct, 2027
(3 years from now) | |
| US8113199 | GLAXO GRP LTD | Counter for use with a medicament dispenser |
Oct, 2027
(3 years from now) | |
|
US8511304 (Pediatric) | GLAXO GRP LTD | Medicament dispenser |
Dec, 2027
(3 years from now) | |
| US8161968 | GLAXO GRP LTD | Medicament dispenser |
Feb, 2028
(3 years from now) | |
|
US9333310 (Pediatric) | GLAXO GRP LTD | Medicament dispenser |
Apr, 2028
(3 years from now) | |
|
US8113199 (Pediatric) | GLAXO GRP LTD | Counter for use with a medicament dispenser |
Apr, 2028
(4 years from now) | |
|
US8161968 (Pediatric) | GLAXO GRP LTD | Medicament dispenser |
Aug, 2028
(4 years from now) | |
| US11116721 | GLAXO GRP LTD | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
Feb, 2029
(4 years from now) | |
|
US11116721 (Pediatric) | GLAXO GRP LTD | Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol |
Aug, 2029
(5 years from now) | |
| US8534281 | GLAXO GRP LTD | Manifold for use in medicament dispenser |
Mar, 2030
(5 years from now) | |
|
US8534281 (Pediatric) | GLAXO GRP LTD | Manifold for use in medicament dispenser |
Sep, 2030
(6 years from now) | |
| US8746242 | GLAXO GRP LTD | Medicament dispenser |
Oct, 2030
(6 years from now) | |
|
US8746242 (Pediatric) | GLAXO GRP LTD | Medicament dispenser |
Apr, 2031
(6 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Patient Population(NPP) | May 13, 2026 |
| New Strength(NS) | May 13, 2026 |
| Pediatric Exclusivity(PED) | Nov 13, 2026 |
| M(M-202) | May 15, 2020 |
| New Product(NP) | May 10, 2016 |
| New Chemical Entity Exclusivity(NCE) | May 10, 2018 |
| New Indication(I-708) | Apr 30, 2018 |
Drugs and Companies using FLUTICASONE FUROATE; VILANTEROL TRIFENATATE ingredient
NCE-1 date: 13 November, 2025
Market Authorisation Date: 12 May, 2023
Treatment: Indicated for long-term, once-daily maintenance treatment of airflow obstruction in pts with copd, including chronic bronchitis and/or emphysema, also to reduce exacerbations of copd in pts with a his...
Dosage: POWDER;INHALATION
BREO ELLIPTA family patents
6. Flovent Diskus 100 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 29 September, 2000
Treatment: NA
Dosage: POWDER;INHALATION
FLOVENT DISKUS 100 family patents
7. Flovent Diskus 250 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 29 September, 2000
Treatment: NA
Dosage: POWDER;INHALATION
FLOVENT DISKUS 250 family patents
8. Flovent Diskus 50 patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5873360 | GLAXO GRP LTD | Inhalation device |
Feb, 2016
(8 years ago) | |
|
US5873360 (Pediatric) | GLAXO GRP LTD | Inhalation device |
Aug, 2016
(7 years ago) | |
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 29 September, 2000
Treatment: NA
Dosage: POWDER;INHALATION
FLOVENT DISKUS 50 family patents
9. Flovent Hfa patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6251368 | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Dec, 2012
(11 years ago) | |
|
US6251368 (Pediatric) | GLAXO GRP LTD | Pharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant |
Jun, 2013
(10 years ago) | |
| US6596260 | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Aug, 2014
(9 years ago) | |
| US5658549 | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Aug, 2014
(9 years ago) | |
| US5674472 | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Oct, 2014
(9 years ago) | |
|
US6596260 (Pediatric) | GLAXO GRP LTD | Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol |
Feb, 2015
(9 years ago) | |
|
US5658549 (Pediatric) | GLAXO GRP LTD | Aerosol formulations containing propellant 134a and fluticasone propionate |
Feb, 2015
(9 years ago) | |
|
US5674472 (Pediatric) | GLAXO GRP LTD | Canisters containing aerosol formulations containing P134a and fluticasone propionate |
Apr, 2015
(9 years ago) | |
| US6966467 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6315173 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6510969 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6170717 | GLAXO GRP LTD | Valve for aerosol container |
Dec, 2017
(6 years ago) | |
| US6997349 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6435372 | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jan, 2018
(6 years ago) | |
| US6938796 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6161724 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US7143908 | GLAXO GRP LTD | Indicating device |
Jan, 2018
(6 years ago) | |
| US6431168 | GLAXO GRP LTD | Dispenser with doses′ counter |
Jun, 2018
(5 years ago) | |
| US7107986 | GLAXO GRP LTD | Dispenser with doses' counter |
Jun, 2018
(5 years ago) | |
|
US6315173 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6170717 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6966467 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6510969 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Jun, 2018
(5 years ago) | |
|
US6161724 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US7143908 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6997349 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6938796 (Pediatric) | GLAXO GRP LTD | Indicating device |
Jul, 2018
(5 years ago) | |
|
US6435372 (Pediatric) | GLAXO GRP LTD | Delivery system for a medicament and method for the assembly thereof |
Jul, 2018
(5 years ago) | |
| US7350676 | GLAXO GRP LTD | Valve for aerosol container |
Aug, 2018
(5 years ago) | |
|
US7107986 (Pediatric) | GLAXO GRP LTD | Dispenser with doses' counter |
Dec, 2018
(5 years ago) | |
|
US6431168 (Pediatric) | GLAXO GRP LTD | Dispenser with doses′ counter |
Dec, 2018
(5 years ago) | |
|
US7350676 (Pediatric) | GLAXO GRP LTD | Valve for aerosol container |
Feb, 2019
(5 years ago) | |
| US9861771 | GLAXO GRP LTD | Device housing for an aerosol container |
Oct, 2020
(3 years ago) | |
| US6743413 | GLAXO GRP LTD | Suspension aerosol formulations |
Jun, 2021
(2 years ago) | |
|
US6743413 (Pediatric) | GLAXO GRP LTD | Suspension aerosol formulations |
Dec, 2021
(2 years ago) | |
| US7832351 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Jun, 2023
(10 months ago) | |
|
US7832351 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Dec, 2023
(4 months ago) | |
| US7500444 | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Feb, 2026
(1 year, 10 months from now) | |
|
US7500444 (Pediatric) | GLAXO GRP LTD | Actuation indicator for a dispensing device |
Aug, 2026
(2 years from now) | |
Drugs and Companies using FLUTICASONE PROPIONATE ingredient
Market Authorisation Date: 14 May, 2004
Treatment: A method of treating respiratory disorders, e.g., asthma, which comprises administration by inhalation of an effective amount of a pharmaceutical formulation as claimed in us patent no. 5658549; Metho...
Dosage: AEROSOL, METERED;INHALATION
FLOVENT HFA family patents